Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- BIOR
- Price
- 0.22
- Stock movement up
- +- (0.00%)
- Company name
- Biora Therapeutics Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 994.99K
- Ent value
- 118.93M
- Price/Sales
- 1.12
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return (CAGR)
- 0.00%
- 3 year return (CAGR)
- -80.68%
- 5 year return (CAGR)
- -82.65%
- 10 year return (CAGR)
- -
Last updated: 2026-02-20
DIVIDENDS
BIOR does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 1.12 |
| Price to Book | - |
| EV to Sales | 133.33 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 4.52M |
| EPS (TTM) | -8.63 |
| FCF per share (TTM) | -1.90 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 892.00K |
| Gross profit (TTM) | 677.00K |
| Operating income (TTM) | -60.87M |
| Net income (TTM) | -31.54M |
| EPS (TTM) | -8.63 |
| EPS (1y forward) | -7.21 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 75.90% |
| Operating margin (TTM) | -6824.33% |
| Profit margin (TTM) | -3535.76% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 3.20M |
| Net receivables | 868.00K |
| Total current assets | 6.05M |
| Goodwill | 6.07M |
| Intangible assets | 0.00 |
| Property, plant and equipment | 4.59M |
| Total assets | 14.51M |
| Accounts payable | 6.92M |
| Short/Current long term debt | 39.65M |
| Total current liabilities | 120.62M |
| Total liabilities | 121.13M |
| Shareholder's equity | -106.63M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -5.37M |
| Capital expenditures (TTM) | 280.00K |
| Free cash flow (TTM) | -6.95M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -217.44% |
| Return on Invested Capital | 38.62% |
| Cash Return on Invested Capital | 8.51% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.22 |
| Daily high | 0.22 |
| Daily low | 0.22 |
| Daily Volume | 0K |
| All-time high | 2992.50 |
| 1y analyst estimate | 34.00 |
| Beta | 1.28 |
| EPS (TTM) | -8.63 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| BIOR | S&P500 | |
| Current price drop from All-time high | -99.99% | -1.82% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 30 Dec 2024 | 9 Mar 2009 |
| Avg drop from high | -87.64% | -10.84% |
| Avg time to new high | 714 days | 12 days |
| Max time to new high | 1428 days | 1805 days |
COMPANY DETAILS
Marketcap
994.99K
Marketcap category
Small-cap
Description
Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California. On December 27, 2024, Biora Therapeutics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Employees
58
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner